A cohort study of Covid-19 test positive and negative patients to detect and provide early treatment for mental health disorders
- Funded by Canadian Institutes of Health Research (CIHR), MOH
- Total publications:1 publications
Grant number: 173104
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$152,729.19Funder
Canadian Institutes of Health Research (CIHR), MOHPrincipal Investigator
Simon HatcherResearch Location
CanadaLead Research Institution
Ottawa Hospital Research Institute/Institut de recherche de l'Hôpital d'OttawaResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
There has been ample speculation about how the COVID-19 pandemic and lockdown may affect mental health. This proposal aims to screen patients who have been infected with Covid-19 to see how many experience symptoms of mental illness 1 year after testing compared to individuals who tested negative. Participants will complete measures of depression, anxiety, post-traumatic stress disorder, quality of life, and cognitive skills. They will complete these assessments at 6, 9 and 12 months after their first test. Using this study, we hope to better understand the prevalence and nature of mental illness that occurs during and after this global pandemic. Results from this study will also provide information for prevention, screening programmes and service delivery for mental health disorders during COVID-19 so that access can be matched to highest needs
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC